Links
Organizations
Conferences
Info & Opinion
- Applied Clinical Trials
- Bio-IT World
- ClinPsych
- Clinical Trials Today
- Tom Lamb
- George Laszlo
- Pharma Voice
- Ed Silverman
- TJOLS
December 3, 2008
New (Free) U.S. Guide To Phase IV
Outcome: Why Good Registries Matter
A thought leader in the post-approval space, Outcome’s Richard Gliklich talks about a new reference work that he had a hand in. He believes well-designed registries could put regulatory agencies, academic experts and the general public at ease.
Post-Approval Summit
Politician, Serono Speak at Meeting
Two divergent presentations at the Post-Approval Summit at the Harvard conference this week in Boston.
- Home
- Tag
- gliklich
With Congress poised to legislate new mandates for post-approval studies, it seemed like a good time to talk to Richard Gliklich, the president of Outcome and a professor of surgery at Harvard Medical School. We covered his company’s substantive conference…
The Post-Approval Summit at Harvard, now in its third year, is the most cerebral conference on our calendar. It is also the meeting most larded with VIP speakers, including a preponderance of physicians who run a) large swaths of international…
